甲硝唑相关Stevens-Johnson综合征1例及文献回顾OA
Metronidazole-related Stevens-Johnson syndrome:a case report and literature review
目的 分析甲硝唑相关史蒂文斯-约翰逊综合征(Stevens-Johnson syndrome,SJS)的临床特征及诊疗方案,为口腔围手术期用药安全提供临床参考.方法 获得单位伦理委员会批准,遵循赫尔辛基宣言,回顾性纳入1例下颌阻生牙拔除术后口服甲硝唑后发病的SJS病例.对中国知网、万方、PubMed、Web of Science数据库中报道的甲硝唑相关 SJS 病例进行检索及文献复习,分析人口学特征、用药方案、发病潜伏期、临床体征、干预措施及预后结局.结果 本院1例SJS患者临床表现为唇部肿胀,口腔黏膜广泛糜烂、溃疡,伴剧烈吞咽疼痛,躯干及四肢出现散在红斑、水疱,尼氏征阳性;会阴部皮肤、阴茎头表面黏膜出现糜烂,阴囊皮肤剥脱.经停用甲硝唑,先后予以糖皮质激素、免疫调节剂、静脉注射免疫球蛋白及血浆置换等综合救治后病情逐步缓解,随访 14 个月仅遗留轻度眼干,皮肤黏膜未遗留明显瘢痕,无其他严重后遗症,该病例因早期未能及时识别预警症状,存在停药与临床干预延迟问题.文献复习检索到6例甲硝唑相关 SJS 病例,其中男 3 例、女 3 例,年龄 31~61 岁,中位年龄 45.5 岁;甲硝唑用于十二指肠溃疡穿孔修补术后败血症抗感染、消化系统感染、黏膜病、盆腔炎、脓毒性蜂窝织炎合并肺炎及牙龈炎抗感染治疗各 1 例;给药途径包括口服 2 例、静脉给药 3 例、局部外用 1 例;用药至发病潜伏期 0.25~7 d,中位潜伏期 4 d.全部病例均见口腔黏膜糜烂,有5例尼氏征阳性.临床均以停用致敏药物为基础治疗,部分联合免疫调控、对症支持及多学科协作诊疗.预后个体差异较大,采用"停药+糖皮质激素+支持治疗"方案的4例中,3例痊愈,1例好转,采用"停药+单纯支持治疗"方案的2例中,1例痊愈,1例死亡.结论 甲硝唑相关 SJS 虽临床罕见,但进展迅猛,口腔黏膜损害普遍,发病多集中于用药后 1 周内.早期停用致敏药物并尽早启动糖皮质激素干预可改善患者预后.口腔围手术期应严格把控甲硝唑用药指征、强化早期症状监测预警并建立多学科协作诊疗模式,从源头降低重症药物不良反应发生风险.
Objective To analyze the clinical characteristics and management strategies of metronidazole-associated Stevens-Johnson syndrome(SJS),and to provide a clinical basis for medication safety during the oral periop-erative period.Methods The study adhered to the tenets of the Declaration of Helsinki and was approved by the Eth-ics Committee of Stomatological Hospital of Xi'an Jiaotong University.A retrospective analysis was conducted on a case of SJS following mandibular impacted tooth extraction,for which the patient had taken metronidazole.Additionally,a lit-erature review was performed by searching databases including China National Knowledge Infrastructure,Wanfang,PubMed,and Web of Science to identify reported cases of metronidazole-associated SJS.Demographic features,medica-tion regimens,latency periods,clinical signs,interventions,and prognosis were analyzed.Results The patient pre-sented with lip swelling,extensive erosion and ulceration of the oral mucosa,and severe odynophagia.Scattered ery-thematous macules and bullae were observed on the trunk and extremities,with a positive Nikolsky sign.Additionally,there was erosion of the perineal skin and glans penis mucosa,along with skin desquamation of the scrotum.The pa-tient with SJS was managed in the hospital by discontinuing metronidazole and administering sequential treatments,in-cluding glucocorticoids,immunomodulators,intravenous immunoglobulin,and plasma exchange.The condition gradu-ally improved;after a 14-month follow-up,only mild dry eye remained,with no significant scarring of the skin or mu-cosa.However,delayed recognition of early warning signs resulted in delayed drug withdrawal and intervention.The lit-erature review identified 6 additional cases(3 males,3 females)with a median age of 45.5 years(range 31-61).Indica-tions for metronidazole included postoperative sepsis prophylaxis after duodenal ulcer perforation repair,digestive sys-tem infections,mucosal diseases,pelvic inflammatory disease,septic cellulitis with pneumonia,and gingivitis.Adminis-tration routes comprised oral(n=2),intravenous(n=3),and topical(n=1).The latency period from drug administra-tion to onset ranged from 0.25 to 7 days(median 4 days).All of the cases presented with oral mucosal erosion,and a positive Nikolsky's sign was noted for five patients.Discontinuation of the causative drug was the cornerstone of treat-ment,supplemented by immunomodulatory therapy,symptomatic support,and multidisciplinary collaboration.Progno-ses varied significantly:among the four patients treated with"drug withdrawal+glucocorticoids+supportive care,"three recovered fully and one improved;among the two patients receiving"drug withdrawal+simple supportive care,"one recovered and one died.Conclusion Although metronidazole-associated SJS is rare,it progresses rapidly and fre-quently involves oral mucosal damage,typically occurring within one week of administering the medication.Early drug withdrawal and prompt initiation of glucocorticoid therapy can improve prognosis.During the oral perioperative period,strict adherence to metronidazole indications,enhanced monitoring for early warning symptoms,and the establishment of a multidisciplinary collaborative diagnosis and treatment model are essential to minimize the risk of severe adverse drug reactions.
石海波;刘长阳;那思家;李兴强
西安交通大学口腔医院 陕西省颅颌面精准医学研究重点实验室,陕西 西安(710004)||西安交通大学口腔医院头颈肿瘤外科,陕西 西安(710004)西安交通大学口腔医院 陕西省颅颌面精准医学研究重点实验室,陕西 西安(710004)||西安交通大学口腔医院头颈肿瘤外科,陕西 西安(710004)西安交通大学口腔医院 陕西省颅颌面精准医学研究重点实验室,陕西 西安(710004)||西安交通大学口腔医院口腔外科,陕西 西安(710004)西安交通大学口腔医院 陕西省颅颌面精准医学研究重点实验室,陕西 西安(710004)||西安交通大学口腔医院头颈肿瘤外科,陕西 西安(710004)
医药卫生
甲硝唑史蒂文斯-约翰逊综合征口腔围手术期药物不良反应用药安全临床防治预后分析
metronidazoleStevens-Johnson syndromeoral perioperative periodadverse drug reactionmedication safetyclinical prevention and treatmentprognostic analysis
《口腔疾病防治》 2026 (7)
688-695,8
陕西省卫生健康口腔颌面外科科研创新团队项目(2024TD-19) This study was funded by Research Innovation Team of Oral and Maxillofacial Surgery of Shaanxi Provincial Health Commis-sion(No.2024TD-19).The funder had no role in the study design,data collection and analysis,decision to publish,or preparation of the manu-script.
评论